Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what drugs were used to treat people exposed to Novichock in Wiltshire in 2019; and what testing those drugs were subject to.

Only medicines licensed for use either as recognised treatments for organophosphate poisoning, or ordinarily used for supportive care in normal resuscitative and intensive care practice were used to treat those symptomatic people recognised as having been exposed to Novichok nerve agent.

For all licensed medicines, robust scientific data is required to demonstrate that the products meet acceptable standards of safety, quality and efficacy before they are placed on the market.